SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Marshall Teitelbaum who wrote (1677)10/19/1998 11:33:00 PM
From: Dr. Bob  Read Replies (1) | Respond to of 2205
 
Thanks, Marshall. I just thought LIFC looked good because they were executing on a plan which looked like they would become profitable by next year, giving them a head start on the competition, with other products (such as Thrombosol) coming on line later when the competition started to heat up for skin/tissue replacements. But I try to follow the competition, too, so I was interested in your earlier comment.

Thanks again!

Bob


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News